Transgene SA TRGNF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 326.20% | 317.19% | -- |
| Total Other Revenue | -39.10% | -33.93% | -8.02% | -10.43% | 43.83% |
| Total Revenue | -33.02% | -27.33% | -4.10% | -6.61% | 43.83% |
| Cost of Revenue | -11.74% | -4.25% | -7.41% | -9.84% | 22.45% |
| Gross Profit | 4.43% | -3.68% | 8.04% | 10.45% | -16.50% |
| SG&A Expenses | 11.66% | 21.15% | 20.29% | 17.13% | -12.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 453.59% | 483.10% | 1,144.44% | 1,110.39% | 55.91% |
| Total Operating Expenses | -6.55% | 1.39% | 1.68% | -0.98% | 14.94% |
| Operating Income | -0.56% | -9.10% | -2.59% | 0.10% | -9.05% |
| Income Before Tax | 16.78% | 9.71% | -13.85% | -10.86% | -23.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.78% | 9.71% | -13.85% | -10.86% | -23.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.78% | 9.71% | -13.85% | -10.86% | -23.42% |
| EBIT | -0.56% | -9.10% | -2.59% | 0.10% | -9.05% |
| EBITDA | -0.41% | -8.93% | -2.34% | 0.35% | -8.80% |
| EPS Basic | 59.81% | 56.40% | 3.69% | 6.20% | 6.03% |
| Normalized Basic EPS | 59.69% | 56.37% | 3.64% | 6.39% | 6.01% |
| EPS Diluted | 58.99% | 55.51% | 4.78% | 7.22% | 3.19% |
| Normalized Diluted EPS | 59.69% | 56.37% | 3.64% | 6.39% | 6.01% |
| Average Basic Shares Outstanding | 107.05% | 107.05% | 18.26% | 18.26% | 31.26% |
| Average Diluted Shares Outstanding | 107.05% | 107.05% | 18.26% | 18.26% | 31.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |